A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


September 24, 2010

HIV Drug Isentress Could Fight All Herpes Viruses

The integrase inhibitor Isentress (raltegravir) could lead to the development of an effective treatment against all herpes viruses, including strains that can cause blindness and cancer, according to an announcement by researchers from the Institute for Research in Biomedicine (IRB) in Barcelona. The researchers’ complete findings were published online August 30 in the Proceedings of the National Academy of Sciences.

Miquel Coll, PhD, the senior author of the paper and a researcher at the IRB, has been working for some time with his fellow researchers to help resolve the structural proteins that help herpes viruses reproduce.

The herpes family includes herpes simplex, which can cause oral or genital ulcers; herpes zoster (varicella), which causes chickenpox and shingles; Epstein-Barr virus, which is associated with several types of cancer; cytomegalovirus, which can lead to blindness and potential worsen the course of HIV disease; and Human Herpes Virus-8, which can cause Kaposi’s sarcoma.

One step in the herpes replication process takes place within the nucleus of a target human cell, where the human DNA is contained. The herpes virus is able to hijack the human DNA to make long strands of viral DNA. To form new infectious viruses, however, these long DNA strands must be chopped up and repackaged. The molecular complex responsible for this process is called terminase, and that’s where Coll and his colleagues have been focusing, as this complex is shared by all of the herpes family of viruses.

When the researchers built a 3D model of the terminase, they realized that it strongly resembled the HIV integrase protein of HIV. Given that Isentress binds to this protein, and is an approved drug with a known safety profile, Coll’s group next explored whether Isentress would bind to the herpes terminase, which it did. The next step is to test Isentress in cell cultures and determine its effect on a variety of herpes strains.

“These results have a clear medical impact,” Coll said. “Now we must do the assays on whole infected cells, improve the effect of the drug and validate that it is also effective for other kinds of herpes viruses.”

Search: Herpes, zoster, Epstein-Barr, varicella, cytomegalovirus, CMV, HHV8, Kaposi's sarcoma, Miguel Coll, Isentress, raltegavir, integrase inhibitor,

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (10 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.